Medifast Stock Price and Value Analysis

Should you buy Medifast stock? (NYSE:MED). Let's see how it does in our automated value investing analysis system.

MED Free Cash Flow Trend

Free Cash Flow trendline for MED
Free Cash Flow trendline for Medifast

Based on historical returns, we believe that Medifast can grow its free cash at a rate of about 3%. That's positive!

  • This company has a large dividend yield!
  • This company is solid.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.

Inside the MED Numbers

MED Price
(Medifast stock price per share)
[?] MED Fair Price
(based on intrinsic value)
[?] MED Safety Price (based on a variable margin of safety) $17.72
[?] PE Ratio versus Sector 43% higher than other Consumer Goods stocks
[?] PE Ratio versus Industry 6% lower than other Personal Services stocks
[?] Cash Yield 2.27%
[?] Free Cash Flow Jitter 89%
[?] Dividend Yield 3%

Is Medifast Stock on Sale?

We believe that Medifast may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Medifast looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy MED Stock?

Does Medifast have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.